Product Information
PAROXETINE HCL 30 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0947 per EA under NDC 62135054390. Its NADAC has been published 146 times since Sep 13, 2023.
Strength
30 mg/1
Manufacturer
Chartwell RX LLCNDC
62135054390
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211248On Market Since
11/2/2021
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 30 MG TABLET has been published 146 times since Sep 13, 2023, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0947 per EA |
|---|---|
| All-time high | $0.1154 (Jan 10, 2024) |
| All-time low | $0.0735 (Nov 20, 2024) |
| 52-week high | $0.1098 |
| 52-week low | $0.0946 |
| Median price | $0.0971 |
| Average price | $0.0978 |
| Largest weekly change | +27.2% (Nov 22, 2023) |
| Weeks tracked | 146 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PAROXETINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 30 MG TABLET, manufactured by Chartwell RX LLC, is $0.0947 per EA (NDC 62135054390), effective Jun 24, 2026.
How has the price of PAROXETINE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 30 MG TABLET has declined 4.4%. It has been tracked across 146 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 30 MG TABLET?
Since Sep 13, 2023, the NADAC for PAROXETINE HCL 30 MG TABLET has ranged from a low of $0.0735 (Nov 20, 2024) to a high of $0.1154 (Jan 10, 2024), with a median of $0.0971 per EA.
Are there cheaper alternatives to PAROXETINE HCL 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PAROXETINE HCL 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE HCL 30 MG TABLET?
PAROXETINE HCL 30 MG TABLET (NDC 62135054390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification